Healthcare -
Biotechnology - NASDAQ - US
$ 29.3
-1.31 %
$ 1.73 B
Market Cap
-22.89
P/E
JANX - STOCK-BASED COMPENSATION
Stock-based Compensation JANX - Janux Therapeutics, Inc.
33 M
LAST VALUE
38.54%
2 YEAR CAGR
459.92%
5 YEAR CAGR
0.00%
10 YEAR CAGR